2
Clinical Trials associated with LK-Neo TCR-T (Likang Life Sciences)Clinical study of safety, tolerance and efficacy of neoantigen targeting T cells suspension for intravenous infusion (Neo-T) in the treatment of patients with advanced solid tumor
Phase Ia clinical study of safety, tolerance and efficacy of neoantigen targeting T cells suspension for intravenous infusion (Neo-T) in the treatment of patients with Advanced solid tumor
100 Clinical Results associated with LK-Neo TCR-T (Likang Life Sciences)
100 Translational Medicine associated with LK-Neo TCR-T (Likang Life Sciences)
100 Patents (Medical) associated with LK-Neo TCR-T (Likang Life Sciences)
100 Deals associated with LK-Neo TCR-T (Likang Life Sciences)